Medlive Technology Co., Ltd.

SEHK:2192 Rapporto sulle azioni

Cap. di mercato: HK$5.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Medlive Technology Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Liping Tian

Amministratore delegato

CN¥4.8m

Compenso totale

Percentuale dello stipendio del CEO35.8%
Mandato del CEO11.3yrs
Proprietà del CEO1.1%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione6.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 04
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Apr 08
Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Feb 20
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Jan 10
Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 27
Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Jul 10
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

May 11
Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

May 02
Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 26
Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

Feb 06
Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Oct 31
There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 14
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Apr 03
These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Feb 22
Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Liping Tian rispetto agli utili di Medlive Technology?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

CN¥290m

Mar 31 2024n/an/a

CN¥266m

Dec 31 2023CN¥5mCN¥2m

CN¥242m

Sep 30 2023n/an/a

CN¥216m

Jun 30 2023n/an/a

CN¥189m

Mar 31 2023n/an/a

CN¥153m

Dec 31 2022CN¥7mCN¥2m

CN¥117m

Sep 30 2022n/an/a

CN¥83m

Jun 30 2022n/an/a

CN¥48m

Mar 31 2022n/an/a

CN¥44m

Dec 31 2021CN¥7mCN¥1m

CN¥41m

Sep 30 2021n/an/a

CN¥55m

Jun 30 2021n/an/a

CN¥70m

Mar 31 2021n/an/a

CN¥78m

Dec 31 2020CN¥816kCN¥816k

CN¥85m

Dec 31 2019CN¥756kCN¥756k

CN¥31m

Dec 31 2018CN¥736kCN¥736k

CN¥14m

Compensazione vs Mercato: La retribuzione totale di Liping ($USD 678.35K ) è superiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 472.69K ).

Compensazione vs guadagni: La retribuzione di Liping è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Liping Tian (57 yo)

11.3yrs

Mandato

CN¥4,839,000

Compensazione

Ms. Liping Tian is Chairwoman and Chief Executive Officer of Medlive Technology Co. Ltd. Ms. Tian has been Executive Director of Medlive Technology Co. Ltd since April 2013. She has been the executive dire...


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Liping Tian
Chairwoman & CEO11.3yrsCN¥4.84m1.1%
CN¥ 65.0m
Lixin Tian
President10.7yrsCN¥2.14m0.27%
CN¥ 16.1m
Lijun Tian
VP, Deputy Head of Medical Information Science Research Unit & Executive Director10.7yrsCN¥2.04m0.21%
CN¥ 12.6m
Xin Zhou
VP & Executive Director6.1yrsCN¥673.00kNessun dato
Richard L. Yeh
Independent Non-Executive Director3.6yrsCN¥120.00kNessun dato
Eiji Tsuchiya
Non-Executive Director10.7yrsNessun datoNessun dato
Jun Ma
Independent Non-Executive Director3.6yrsCN¥120.00kNessun dato
Shan Wang
Independent Non-Executive Director3.6yrsCN¥120.00kNessun dato
Kazutaka Kanairo
Non-Executive Director1.3yrsNessun datoNessun dato

6.1yrs

Durata media

55yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 2192 sono considerati esperti (durata media dell'incarico 6.1 anni).